Corporate Partners
Our corporate and organizational partners contributed to the development and implementation of world class initiatives. This year, our patients and professionals benefited from this support through key programs such as the Kidney Early Evaluation Program, NKF Clinical Meetings, World Kidney Day, educational resources and clinical practice guidelines developed through the Kidney Disease Outcomes Quality Initiative (KDOQI). For additional information please contact us.
2009 Corporate Partners
$1,000,000 +Abbott Amgen Genzyme $500,000-$999,999Pfizer $250,000-$499,999Fresenius Novartis Pharmaceuticals Roche Siemens University of Pittsburgh Medical Center Vifor Pharmaceuticals |
$100,000-$249,999Advisor Charitable Gift Fund Affymax AMAG Bristol-Myers Squibb CB Richard Ellis Genentech GlaxoSmithKline Centocor Ortho Biotech Nephroceuticals Novo Nordisk Questcor Pharmaceuticals Sanofi-Aventis United Way Wyeth $50,000-$99,999AT&T Chugai Pharmaceuticals The Coca Cola Company CSL Behring Discovery Communications Froedtert Hospital GE Healthcare Kyowa Kirin Merck National Council of Corvette Clubs, Inc. PING Watson Laboratories |
$10,000-$49,999Amerigroup Charitable Fund Alaska Kidney Foundation Astellas Avera McKennan Hospital and University Health Center Charley’s Grilled Subs Condé Nast Publications First Republic Bank Mayo Foundation Musculoskeletal Transplant Foundation PharmaNet Development Group, Inc. Phi Sigma Sigma Foundation Shire Pharmaceuticals Strides for IgA Nephropathy Takeda Pharmaceuticals United Healthcare Services Wachovia Securities Wasserman Foundation |
Corporate Relations Policy (PDF* 115 kb)
